✦ LIBER ✦

O94 Feasibility of warfarin therapy in carriers of allelic variants of CYP2C9

✍ Scribed by J. Ablin; A. Eldor; H. Peretz; A. Lagziel; S. Cabili

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Functional characterization of 32 CYP2C9

✍ Niinuma, Y; Saito, T; Takahashi, M; Tsukada, C; Ito, Mi; Hirasawa, N; Hiratsuka, 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 755 KB

A clinically significant interaction bet

✍ Andersson, Marine L; Eliasson, Erik; Lindh, Jonatan D 📂 Article 📅 2012 🏛 Future Medicine 🌐 English ⚖ 654 KB

First report of warfarin dose requiremen

✍ O'Brien, Travis J.; Kidd, Robert S.; Richard, Craig A.H.; Ha, Ngoc-Han; Witcher, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 546 KB

Frequency of CYP2C9 variant alleles, inc

✍ H. W. Lee; M.-s. Lim; J. Lee; M.-Y. Jegal; D.-W. Kim; W.-K. Lee; I.-J. Jang; J.- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

CYP2C9*3allelic variant is associated wi

✍ Xiumei Hong; Shanchun Zhang; Guangyun Mao; Shanqun Jiang; Yan Zhang; Yunxian Yu; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 242 KB

Influence of CYP2C9 and VKORC1 on warfar

✍ N.A. Limdi; H. Wiener; J.A. Goldstein; R.T. Acton; T.M. Beasley 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 516 KB